Added to YB: 2025-06-11
Pitch date: 2025-06-08
HIMS [bullish]
Hims & Hers Health, Inc.
-34.96%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$8.9B
Pitch Price
$57.21
Price Target
N/A
Dividend
N/A
EV/EBITDA
52.94
P/E
73.02
EV/Sales
4.26
Sector
Health Care Providers and Services
Category
growth
HIMS is really more than just an online drug company. Their next move is very interesting.
HIMS: Moving beyond DTC drugs to hormone health platform with TRT (20-25M US men market) & menopause care (50M US women) launching H2 2025. Strategy leverages existing customer base with online diagnosis & home delivery. At just 1% market penetration = $230M annual rev by 2030; 3-5% = $700M-$1.15B potential.
Read full article (2 min)